I examine the effect of pharmaceutical innovation on the functional status of nursing home residents using cross … have been 58%, instead of 50%. During the period 1990-2004, pharmaceutical innovation reduced the functional limitations of …

I examine the effect of pharmaceutical innovation on the functional status of nursing home residents using cross … of 50%. During the period 1990-2004, pharmaceutical innovation reduced the functional limitations of nursing home …

I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the … pre‐dated factors that drove both innovation and mortality and that there would have been parallel trends in mortality in … the absence of innovation, the estimates indicate that there were three major sources of the 13.8% decline of the age …

I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003-2013, by ….) that were subject to more pharmaceutical innovation, controlling for changes in the age-standardized cancer incidence rate … of cancer drug innovation to Mexican longevity growth has been valuable, but, perhaps, it could have been even larger …